Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WeRide Inc. Board/Management Information 2002

Dec 17, 2002

49472_rns_2002-12-17_0396bd79-ca7d-4663-955e-3ca54ce311f5.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED 遠東生物制藥科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(the “Company”)

APPOINTMENT OF EXECUTIVE DIRECTOR

Mr. Tso Ming Sing, Barton has appointed as Managing Director

This is to announce that with effect from 17 December, 2002 Mr. Tso Ming Sing, Barton has been appointed as a managing director of the Company.

Mr. Tso Ming Sing, Barton, graduated from the International Finance Department of Shanghai Fudan University with as Bachelor of Economics. Mr. Tso has over 15 years of experience in the banking business, information technology, corporate governance, financial accounting, securities fund, investment consultant and the steering and strategic planning of the successful distribution of international renowned brandnames in the PRC. Prior to joining the Group, Mr. Tso served as the Managing Director of South Capital Securities Limited and an executive director of Fortune Telecom Holding Limited in Hong Kong.

On behalf of the Board CAI Chong Zhen Chairman

Hong Kong, 17 December, 2002

Please also refer to the published version of this announcement in the Standard.

– 1 –